GRAIL, Inc. - Common Stock (NQ:GRAL)

GRAIL (NASDAQ:GRAL) reported 4% revenue growth for the third quarter of 2026 as higher testing volumes were offset in part by lower prices, and said it expects a U.S. regulatory decision on its Galleri...

What GRAIL (GRAL) Said on Its Q3 Earnings Call ↗

November 04, 2026

Performance

52-Week Range 27.1% below 52-week high

121.44

41.5052W Low 166.4752W High

1 Week 18.5% below 1-week high

117.001W Low 149.001W High

GRAIL, Inc. - Common Stock (GRAL) traded between $41.50 and $166.47 over the past 52 weeks and last traded at $121.44, 27.1% below its 52-week high. Over the past week it ranged between $117.00 and $149.00.

Past 12 Months

-9.2%

-8.6%

+74.8%

+97.0%

+36.6%

+51.7%

1W -$12.32

1M -$11.46

3M +$51.96

6M +$59.80

YTD +$32.57

1Y +$41.38

GRAL was +51.7% over the past year, +97.0% over six months, +36.6% year to date, -9.2% in the last week.

12 Months vs Market

GRAL

+51.7%

DIA

+9.2%

SPY

+9.7%

QQQ

+7.3%

IWM

+13.9%

Over the past 12 months GRAL returned +51.7% versus DIA (Dow) +9.2%, SPY (S&P 500) +9.7%, QQQ (Nasdaq 100) +7.3% and IWM (Russell 2000) +13.9%.

Volume & Liquidity 0.74× 3-mo avg

Today 756,383 3-mo avg 1.0M

1.2M

963.0K

1.0M

854.6K

YTD

961.7K

969.4K

GRAL most recently traded 756,383 shares against a 3-month average daily volume of 1.0M.

More News

GRAIL (NASDAQ:GRAL) Slides After Q3 Revenue Miss Despite Narrower Loss ↗

November 04, 2026

Via Chartmill

5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps ↗

October 26, 2026

Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. ↗

October 11, 2026

2 Growth Stocks to Buy in October ↗

October 08, 2026

Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years? ↗

October 04, 2026

3 Reasons to Buy Grail (GRAL) Hand Over Fist in October ↗

September 30, 2026

Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run. ↗

September 30, 2026

Here's Why Grail Stock Surged 55% This Week ↗

September 25, 2026

Meta's Muse Sends the Nasdaq to a Record and Rekindles the AI Trade ↗

September 22, 2026

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

September 21, 2026

Via Chartmill

Which stocks are experiencing notable movement on Monday? ↗

September 21, 2026

Via Chartmill

Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000 ↗

September 08, 2026

Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test ↗

September 04, 2026

GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting ↗

August 14, 2026

GRAIL (GRAL) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

GRAIL Q2 Earnings Call Highlights ↗

August 05, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL

August 04, 2026

From Pomerantz LLP

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

August 04, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70? ↗

August 01, 2026

GRAL Deadline: Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders to Contact the Firm for Information About Their Rights

July 30, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds GRAIL, Inc. Investors They Have Until August 4th to Contact the Firm Seeking Lead Plaintiff Rol

July 29, 2026

From Bragar Eagel & Squire

GRAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action – GRAL

July 29, 2026

From The Rosen Law Firm PA